NEWS

Valmet to supply a tissue production line to Renova in Portugal

Tuesday, Sep 15, 2015

Valmet will supply an Advantage NTT tissue production line and an automation system to the European tissue brand Renova. Renova is the first tissue producer in Europe to invest in Valmet's Advantage NTT tissue technology for the production of textured and plain tissue products.

The new line, to be installed at the Torres Novas mill in Zibreira, Portugal, will allow Renova to increase its paper production capacity with 50%. The start-up is scheduled for the end of 2016.

The order was included in Valmet's second Quarter 2015 orders received. The value of the order is not disclosed.

"We are eager to see the result from the combination of Renova's proactive innovativeness and Valmet's sustainable Advantage NTT technology. Its flexibility provides endless possibilities to produce special designed textured tissue products," says Mr. Pereira da Silva, CEO of Renova

"Our Advantage NTT technology has established a strong market position in high efficiency innovative and flexible tissue production.  We are excited to support Renova to bring their tissue products to the next level. We are looking forward to working with Renova and making this project a benchmark on the European tissue market," says Jan Erikson, VP Tissue Sales, Valmet.

Technical information of the delivery

The new tissue machine will have a design speed of 1 800 m/min in textured mode and 2,000 m/min in plain mode. The production line is optimized to save energy and fiber as well as add possibilities for product differentiation and increased capacity of premium quality products.

Valmet's scope of delivery comprises a complete tissue production line including an Advantage NTT tissue machine, with an OptiFlo headbox and a cast alloy Yankee cylinder. It will also be featured with the Advantage tissue technology including, an AirCap hood with a WetDust system. Basic and detailed mill engineering, complete stock preparation and process ventilation are also included in the scope. Furthermore, the delivery will include a Valmet DNA Automation system.

 

valmet.com

Other News